✦ LIBER ✦

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

✍ Scribed by Grande, Enrique; Kreissl, Michael C.; Filetti, Sebastiano; Newbold, Kate; Reinisch, Walter; Robert, Caroline; Schlumberger, Martin; Tolstrup, Lærke K.; Zamorano, Jose L.; Capdevila, Jaume

Book ID: 121597578
Publisher: Springer Healthcare Communications
Year: 2013
Tongue: English
Weight: 724 KB
Volume: 30
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-013-0069-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Medullary thyroid cancer: advances in tr

Medullary thyroid cancer: advances in treatment and management of common adverse events associated with therapy

✍ Robert I. Haddad; Rosemary Costello 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 320 KB

Advances in the management of hereditary

Advances in the management of hereditary medullary thyroid cancer

✍ A. MACHENS; J. UKKAT; M. BRAUCKHOFF; O. GIMM; H. DRALLE 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Budget Impact Analysis for the Use of Va

Budget Impact Analysis for the Use of Vandetanib in Mexican Adult Patient Diagnosed with Advanced Unresectable Medullary Thyroid Cancer

✍ Ascencio, I.S.I.; Polanco, A.C.; Ruiz, C.; Pizarro, M.; Soto, H.; Salazar, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

The efficacy of acupoint stimulation for

The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review

✍ Li-Fen Chao; Anthony Lin Zhang; Hsueh-Erh Liu; Ming-Huei Cheng; Hung-Bun Lam; Si 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 280 KB